[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Böger
R H
RH
Institut für Experimentelle und Klinische Pharmakologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg. boeger@uke.uni-hamburg.de
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood* / Q000494:pharmacology; D001161:Arteriosclerosis / Q000097:blood / Q000453:epidemiology; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000378:metabolism; D016022:Case-Control Studies; D002478:Cells, Cultured; D002648:Child; D003327:Coronary Disease / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005609:Free Radicals; D006801:Humans; D006973:Hypertension / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D015999:Multivariate Analysis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D018384:Oxidative Stress; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy; D011446:Prospective Studies; D011817:Rabbits; D012044:Regression Analysis; D006435:Renal Dialysis; D012307:Risk Factors; D020521:Stroke / Q000097:blood
D015415:Biomarkers; D005609:Free Radicals; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase